Mediwound Cost Of Revenue vs Operating Income Analysis

MDWD Stock

USD 16.48 0.28 1.67%

Mediwound financial indicator trend analysis is infinitely more than just investigating Mediwound recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Mediwound is a good investment. Please check the relationship between Mediwound Cost Of Revenue and its Operating Income accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mediwound. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in housing.

For information on how to trade Mediwound Stock refer to our How to Trade Mediwound Stock guide.

Cost Of Revenue vs Operating Income

Cost Of Revenue vs Operating Income Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Mediwound Cost Of Revenue account and Operating Income. At this time, the significance of the direction appears to have almost no relationship.

The correlation between Mediwound's Cost Of Revenue and Operating Income is 0.14. Overlapping area represents the amount of variation of Cost Of Revenue that can explain the historical movement of Operating Income in the same time period over historical financial statements of Mediwound, assuming nothing else is changed. The correlation between historical values of Mediwound's Cost Of Revenue and Operating Income is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Cost Of Revenue of Mediwound are associated (or correlated) with its Operating Income. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Operating Income has no effect on the direction of Cost Of Revenue i.e., Mediwound's Cost Of Revenue and Operating Income go up and down completely randomly.

Correlation Coefficient

0.14

Relationship Direction	Positive
Relationship Strength	Insignificant

View All Relationships

Cost Of Revenue

Cost of Revenue is found on Mediwound income statement and represents the costs associated with goods and services Mediwound provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.

Operating Income

Operating Income is the amount of profit realized from Mediwound operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Mediwound is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.

Most indicators from Mediwound's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Mediwound current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mediwound. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in housing.

For information on how to trade Mediwound Stock refer to our How to Trade Mediwound Stock guide.At present, Mediwound's Tax Provision is projected to increase significantly based on the last few years of reporting. The current year's Enterprise Value is expected to grow to about 145.1 M, whereas Issuance Of Capital Stock is forecasted to decline to about 21.9 M.

	2021	2022	2023	2024 (projected)
Interest Expense	903K	8.9M	427K	405.7K
Depreciation And Amortization	1.2M	1.3M	1.3M	810.5K

Interest Expense Depreciation And Amortization

Mediwound fundamental ratios Correlations

	Common Stock Shares Outstanding	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt
Common Stock Shares Outstanding		0.42	-0.05	0.45	0.55	0.42	0.13	0.98	0.18	-0.73	0.6	0.06	0.28	-0.29	-0.31	0.27	0.36	0.43	-0.04	0.68	-0.17	0.61	0.41	0.98	0.32	-0.48
Total Assets	0.42		0.4	0.38	0.31	0.8	0.3	0.38	-0.48	-0.4	0.32	0.56	-0.18	-0.33	-0.43	0.91	0.34	0.57	0.3	0.72	0.57	0.61	0.49	0.39	0.92	-0.14
Short Long Term Debt Total	-0.05	0.4		-0.24	-0.21	0.09	0.62	-0.05	-0.37	-0.06	-0.1	0.34	-0.57	-0.35	-0.56	0.59	0.03	0.3	0.62	0.29	0.28	0.13	0.49	-0.03	0.55	0.47
Other Current Liab	0.45	0.38	-0.24		0.71	0.12	0.27	0.4	-0.46	-0.71	0.65	0.53	-0.28	-0.65	-0.51	0.4	0.4	0.66	0.21	0.5	-0.01	0.74	0.52	0.37	0.45	-0.32
Total Current Liabilities	0.55	0.31	-0.21	0.71		0.09	0.08	0.53	-0.13	-0.83	0.94	0.22	-0.18	-0.61	-0.49	0.28	0.56	0.75	0.01	0.62	-0.21	0.85	0.45	0.47	0.35	-0.08
Total Stockholder Equity	0.42	0.8	0.09	0.12	0.09		-0.25	0.42	-0.1	-0.14	0.01	0.22	0.31	0.13	0.04	0.59	0.05	0.22	-0.23	0.4	0.54	0.3	-0.04	0.45	0.58	-0.25
Other Liab	0.13	0.3	0.62	0.27	0.08	-0.25		0.04	-0.61	-0.36	0.27	0.61	-0.67	-0.62	-0.72	0.5	0.39	0.38	0.94	0.47	0.0	0.32	0.89	0.06	0.52	0.03
Property Plant And Equipment Net	0.98	0.38	-0.05	0.4	0.53	0.42	0.04		0.25	-0.69	0.57	-0.01	0.32	-0.26	-0.28	0.24	0.23	0.4	-0.12	0.63	-0.16	0.57	0.34	1.0	0.27	-0.45
Net Debt	0.18	-0.48	-0.37	-0.46	-0.13	-0.1	-0.61	0.25		0.25	-0.11	-0.96	0.7	0.54	0.56	-0.68	-0.24	-0.47	-0.7	-0.28	-0.25	-0.36	-0.59	0.25	-0.67	-0.07
Retained Earnings	-0.73	-0.4	-0.06	-0.71	-0.83	-0.14	-0.36	-0.69	0.25		-0.87	-0.41	0.31	0.76	0.72	-0.45	-0.64	-0.88	-0.27	-0.73	0.2	-0.92	-0.68	-0.64	-0.52	0.09
Accounts Payable	0.6	0.32	-0.1	0.65	0.94	0.01	0.27	0.57	-0.11	-0.87		0.19	-0.22	-0.64	-0.55	0.28	0.65	0.77	0.17	0.74	-0.23	0.87	0.59	0.51	0.37	-0.12
Cash	0.06	0.56	0.34	0.53	0.22	0.22	0.61	-0.01	-0.96	-0.41	0.19		-0.6	-0.58	-0.61	0.73	0.28	0.54	0.67	0.38	0.22	0.45	0.66	-0.01	0.73	-0.06
Non Current Assets Total	0.28	-0.18	-0.57	-0.28	-0.18	0.31	-0.67	0.32	0.7	0.31	-0.22	-0.6		0.8	0.82	-0.54	-0.3	-0.57	-0.8	-0.17	-0.23	-0.35	-0.66	0.35	-0.54	-0.56
Non Currrent Assets Other	-0.29	-0.33	-0.35	-0.65	-0.61	0.13	-0.62	-0.26	0.54	0.76	-0.64	-0.58	0.8		0.96	-0.6	-0.45	-0.83	-0.67	-0.51	-0.09	-0.72	-0.83	-0.21	-0.63	-0.25
Other Assets	-0.31	-0.43	-0.56	-0.51	-0.49	0.04	-0.72	-0.28	0.56	0.72	-0.55	-0.61	0.82	0.96		-0.7	-0.43	-0.81	-0.75	-0.56	-0.14	-0.69	-0.89	-0.26	-0.72	-0.29
Cash And Short Term Investments	0.27	0.91	0.59	0.4	0.28	0.59	0.5	0.24	-0.68	-0.45	0.28	0.73	-0.54	-0.6	-0.7		0.3	0.67	0.57	0.62	0.62	0.6	0.67	0.24	0.99	0.08
Net Receivables	0.36	0.34	0.03	0.4	0.56	0.05	0.39	0.23	-0.24	-0.64	0.65	0.28	-0.3	-0.45	-0.43	0.3		0.56	0.35	0.58	-0.18	0.64	0.54	0.2	0.42	0.05
Common Stock Total Equity	0.43	0.57	0.3	0.66	0.75	0.22	0.38	0.4	-0.47	-0.88	0.77	0.54	-0.57	-0.83	-0.81	0.67	0.56		0.37	0.73	0.07	0.95	0.66	0.36	0.72	0.22
Non Current Liabilities Total	-0.04	0.3	0.62	0.21	0.01	-0.23	0.94	-0.12	-0.7	-0.27	0.17	0.67	-0.8	-0.67	-0.75	0.57	0.35	0.37		0.32	0.22	0.24	0.86	-0.11	0.58	0.14
Inventory	0.68	0.72	0.29	0.5	0.62	0.4	0.47	0.63	-0.28	-0.73	0.74	0.38	-0.17	-0.51	-0.56	0.62	0.58	0.73	0.32		0.0	0.83	0.67	0.62	0.69	-0.11
Other Current Assets	-0.17	0.57	0.28	-0.01	-0.21	0.54	0.0	-0.16	-0.25	0.2	-0.23	0.22	-0.23	-0.09	-0.14	0.62	-0.18	0.07	0.22	0.0		-0.03	0.09	-0.14	0.56	0.05
Other Stockholder Equity	0.61	0.61	0.13	0.74	0.85	0.3	0.32	0.57	-0.36	-0.92	0.87	0.45	-0.35	-0.72	-0.69	0.6	0.64	0.95	0.24	0.83	-0.03		0.64	0.53	0.67	-0.02
Total Liab	0.41	0.49	0.49	0.52	0.45	-0.04	0.89	0.34	-0.59	-0.68	0.59	0.66	-0.66	-0.83	-0.89	0.67	0.54	0.66	0.86	0.67	0.09	0.64		0.33	0.71	-0.04
Property Plant And Equipment Gross	0.98	0.39	-0.03	0.37	0.47	0.45	0.06	1.0	0.25	-0.64	0.51	-0.01	0.35	-0.21	-0.26	0.24	0.2	0.36	-0.11	0.62	-0.14	0.53	0.33		0.27	-0.48
Total Current Assets	0.32	0.92	0.55	0.45	0.35	0.58	0.52	0.27	-0.67	-0.52	0.37	0.73	-0.54	-0.63	-0.72	0.99	0.42	0.72	0.58	0.69	0.56	0.67	0.71	0.27		0.07
Short Term Debt	-0.48	-0.14	0.47	-0.32	-0.08	-0.25	0.03	-0.45	-0.07	0.09	-0.12	-0.06	-0.56	-0.25	-0.29	0.08	0.05	0.22	0.14	-0.11	0.05	-0.02	-0.04	-0.48	0.07

Click cells to compare fundamentals

Mediwound Account Relationship Matchups

Mediwound fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Common Stock Shares Outstanding	3.9M	3.9M	3.9M	5.0M	9.0M	9.5M
Total Assets	40.6M	31.1M	19.7M	50.0M	66.5M	44.6M
Other Current Liab	569K	4.8M	5.5M	6.3M	5.3M	3.6M
Total Current Liabilities	10.4M	8.3M	10.7M	12.1M	10.8M	7.6M
Total Stockholder Equity	15.2M	7.3M	(4.6M)	10.9M	31.6M	33.2M
Other Liab	13.0M	13.8M	12.2M	26.2M	23.6M	15.9M
Property Plant And Equipment Net	4.5M	4.5M	4.0M	3.6M	15.9M	16.7M
Net Debt	(5.2M)	(15.6M)	(9.7M)	(33.0M)	(5.5M)	(5.8M)
Retained Earnings	(125.8M)	(135.0M)	(148.5M)	(168.1M)	(174.8M)	(183.6M)
Accounts Payable	4.1M	3.0M	4.7M	5.7M	5.5M	3.2M
Cash	7.2M	17.4M	11.0M	33.9M	11.9M	20.9M
Non Current Assets Total	5.0M	4.9M	4.8M	4.2M	16.8M	17.6M
Non Currrent Assets Other	6K	(4.9M)	(4.3M)	(3.8M)	183K	306.7K
Other Assets	48K	6K	469K	364K	327.6K	311.2K
Cash And Short Term Investments	29.5M	21.6M	11.0M	33.9M	41.5M	31.9M
Net Receivables	4.6M	2.8M	2.3M	9.3M	4.4M	4.2M
Liabilities And Stockholders Equity	40.6M	31.1M	19.7M	50.0M	66.5M	44.6M
Non Current Liabilities Total	15.0M	15.5M	13.6M	27.0M	16.4M	16.5M
Inventory	1.6M	1.4M	1.2M	2.0M	2.8M	1.7M
Other Current Assets	216K	646K	439K	650K	889K	844.6K
Other Stockholder Equity	140.9M	142.2M	143.9M	178.9M	206.3M	137.7M
Total Liab	25.4M	23.8M	24.3M	39.1M	34.9M	31.0M
Property Plant And Equipment Gross	4.5M	4.5M	4.0M	3.6M	23.1M	24.2M
Total Current Assets	35.6M	26.2M	15.0M	45.8M	49.7M	38.0M
Accumulated Other Comprehensive Income	(25K)	(17K)	(40K)	(19K)	(5K)	(18.9K)
Intangible Assets	429K	363K	297K	231K	165K	156.8K
Property Plant Equipment	4.5M	4.5M	4.0M	3.6M	4.1M	2.6M
Net Tangible Assets	14.7M	6.9M	(4.9M)	10.7M	9.6M	7.6M
Short Term Investments	0.0	16.9M	22.0M	4.0M	29.7M	31.2M
Current Deferred Revenue	249K	462K	543K	63K	24K	22.8K
Non Current Liabilities Other	11.7M	12.3M	11.8M	10.2M	9.9M	11.3M
Net Invested Capital	15.2M	7.3M	(4.6M)	10.9M	31.6M	33.2M
Net Working Capital	25.2M	17.9M	4.2M	33.8M	38.9M	21.0M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

When determining whether Mediwound is a strong investment it is important to analyze Mediwound's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Mediwound's future performance. For an informed investment choice regarding Mediwound Stock, refer to the following important reports:

How To Invest In Mediwound

Details

Is Mediwound Stock a good investment?

Details

What is Mediwound's Net Worth?

Details

Largest Pharmaceuticals Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mediwound. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in housing.

For information on how to trade Mediwound Stock refer to our How to Trade Mediwound Stock guide.

You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.

Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mediwound. If investors know Mediwound will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mediwound listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(2.16)

Revenue Per Share

2.18

Quarterly Revenue Growth

0.061

Return On Assets

(0.16)

Return On Equity

(0.76)

The market value of Mediwound is measured differently than its book value, which is the value of Mediwound that is recorded on the company's balance sheet. Investors also form their own opinion of Mediwound's value that differs from its market value or its book value, called intrinsic value, which is Mediwound's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mediwound's market value can be influenced by many factors that don't directly affect Mediwound's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Mediwound's value and its price as these two are different measures arrived at by different means. Investors typically determine if Mediwound is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mediwound's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Mediwound Cost Of Revenue vs Operating Income Analysis

Cost Of Revenue vs Operating Income

Cost Of Revenue vs Operating Income Correlation Analysis

Correlation Coefficient

Cost Of Revenue

Operating Income

Mediwound fundamental ratios Correlations

Mediwound Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Mediwound fundamental ratios Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Property Plant And Equipment Gross	+ 1.0	Property Plant And Equipment Net
Total Current Assets	+ 0.99	Cash And Short Term Investments
Property Plant And Equipment Net	+ 0.98	Common Stock Shares Outstanding
Property Plant And Equipment Gross	+ 0.98	Common Stock Shares Outstanding
Other Assets	+ 0.96	Non Currrent Assets Other
Other Stockholder Equity	+ 0.95	Common Stock Total Equity

Cash	- 0.96	Net Debt
Other Stockholder Equity	- 0.92	Retained Earnings
Total Liab	- 0.89	Other Assets
Common Stock Total Equity	- 0.88	Retained Earnings
Accounts Payable	- 0.87	Retained Earnings
Total Liab	- 0.83	Non Currrent Assets Other